Fairway Wealth’s Amgen AMGN Stock Holding History

Fairway Wealth’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19	Closed	-$6.22K	–	196
2025 Q4	$6.22K	Buy	+19	New	+$6.03K	﹤0.01%	167
2025 Q2	–	Sell	-37	Closed	-$11.5K	–	183
2025 Q1	$11.5K	Sell	37 -270	-88%	-$79.7K	﹤0.01%	155
2024 Q4	$80K	Buy	+307	New	+$91.1K	0.04%	81
2024 Q3	–	Sell	-66	Closed	-$20.6K	–	121
2024 Q2	$20.6K	Buy	+66	New	+$19.4K	0.01%	93

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fairway Wealth's AMGN Position: Q1 2026 in Review

Fairway Wealth sold out of Amgen (AMGN) in Q1 2026, closing a stake of 19 shares — an estimated $6.22K sold.

Fairway Wealth first reported a position in AMGN in Q2 2024 and held it in 4 quarters. The position peaked at $80K in Q4 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Fairway Wealth reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Fairway Wealth sold 19 Amgen shares in Q1 2026, an estimated $6.22K.
Fairway Wealth first reported a position in Amgen in Q2 2024 and held it in 4 quarters.
Fairway Wealth's Amgen position peaked at $80K in Q4 2024.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Fairway Wealth's 13F filing for Q1 2026, filed 23 Apr 2026.